Holen Sie sich die Stockscreener-App
1.325
3.49%
0.035
Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.172 | 1.028 | - |
Operating Expenses
|
30.92%
7.257
|
10.51 | 12.19 | 15.99 | 11.80 |
| Interest Income/Expense |
17.33%
0.725
|
0.877 | 0.943 | 1.124 | 1.337 |
| Benefits Costs and Expenses |
29.49%
7.914
|
11.22 | 12.91 | - | - |
| Costs And Expenses |
29.49%
7.914
|
11.22 | 12.91 | - | - |
| Depreciation and Amortization |
7.08%
0.223
|
0.24 | 0.251 | 0.266 | 0.259 |
| Operating Income/Loss |
30.92%
-7.257
|
-10.51 | -12.01 | -14.96 | -11.80 |
| Income/Loss From Continuing Operations Before Tax |
29.49%
-7.914
|
-11.22 | -12.74 | -15.72 | -12.72 |
| Income/Loss From Continuing Operations After Tax |
29.49%
-7.914
|
-11.22 | -12.74 | -15.72 | -12.72 |
|
Net Income/Loss
|
29.49%
-7.914
|
-11.22 | -12.74 | -15.72 | -12.72 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
44.79%
-2.502
|
-4.532 | -5.474 | -6.775 | -5.939 |
| Basic Average Shares |
27.10%
46.44
|
36.54 | 33.44 | -27.04 | 28.84 |
| Diluted Average Shares |
27.10%
46.44
|
36.54 | 33.44 | -27.04 | 28.84 |
| Basic Earnings Per Share |
33.33%
-0.12
|
-0.18 | -0.22 | -0.27 | -0.24 |
| Diluted Earnings Per Share |
33.33%
-0.12
|
-0.18 | -0.22 | -0.27 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):